Siste oppdatering :
19/11/2024
Forskjellig   Neostigmine methylsulfate  
Injeksjon
Oppløsningsstabilitet Stabilitet i blandinger Faktorer som påvirker stabiliteten Kompatibilitet Administrasjonsmåte Referanser pdf
   Kjemisk struktur  

Handelsnavn   Handelsnavn     

Handelsnavn er veiledende og sammensetning av hjelpestoffer kan være forskjellig avhengig av land og produsent

Adwigmine Egypt
Amostigmine Egypt
Beemine India
Bloxiverz
Epistigmine Egypt
Fadastigmina Argentina, Italia, Portugal
Ipostigmine Iran
Miostin Romania
Neostig Tyskland
Neostigmin Sverige, Tyskland
Neostigmina Argentina, Chile, Colombia, Ecuador, Peru, Portugal, Spania, Venezuela
Neostigmine Australia, Canada, Egypt, Hellas, Irland, Malaysia, Nederland, New Zealand, Saudi-Arabia, Storbritannia, Tyrkia
Neostigmine methylsulfate Canada
Neostigten Peru
Normastigmin Østerrike
Planstigmin Tyrkia
Polstigminum Polen
Prostigmin Belgia, Hellas, Malaysia, Nederland, Sveits, Østerrike
Prostigmina Italia
Prostigmine Belgia, Chile, Colombia, De forente arabiske emirater, Egypt, Frankrike, Luxembourg, Marokko, Mexico, Spania, Venezuela
Setisin Malaysia
Stigmosan Ungarn
Tigmin Peru
Visulmin Mexico
Referanser   Injeksjon   Referanser : Neostigmine methylsulfate  
Type publikasjon
815 Journal Stewart JT, Warren FW, King DT, Venkateshwaran TG, Fox JL.
Stability of ondansetron hydrochloride and 12 medications in plastic syringes.
Am J Health-Syst Pharm 1998 ; 55: 2630-2634.
1200 Journal Chaudry IA, Bruey KP, Hurlburt LE, Oden EM.
Compatibility of netilmycin sulfate injection with commonly used intravenous injections and additives.
Am J Hosp Pharm 1981 ; 38: 1737-1742.
1228 Journal Allen LV, Stiles ML.
Compatibility of various admixtures at Y-injection sites of intravenous administration sets. Part2.
Am J Hosp Pharm 1981 ; 38: 380-381.
1682 Journal Storms M, Stewart JT, Warren FW.
Stability of neostigmine methylsulfate injection at ambient temperature and 4°C in polypropylene syringes.
Int J Pharm Compound 2002 ; 6: 475-477.
2286 Journal Ben M, Trusley C, Kupiec TC, Trissel LA.
Physical and chemical stability of palonosetron hydrochloride with glycopyrrolate and neostigmine during simulated Y-site administration.
Int J Pharm Compound 2008 ; 12, 4: 368-371.
2291 Journal Yeh MK.
Degradation kinetics of neostigmine in solution.
Drug Dev Ind Pharm 2000 ; 26, 11: 1221-1226.
3372 Journal Hanci V, Ali Kiraz H, Ömür D, Ekin S, Uyan B, Yurtlu B.S.
Precipitation in Gallipoli: Sugammadex / Amiodarone & Sugammadex / Dobutamine & Sugammadex / Protamine.
Rev Bras Anestesiol 2013 ; 63, 1: 163-166.
3578 Labratorium Cisplatin - Summary of Product Characteristics
Accord Healthcare 2011
3599 Labratorium Glycopyrrolate Injection U.S.P. - Summary of Product Characteristics
Amco Amdipharm Mercry 2013
3644 Labratorium Calcium gluconate® - Summary of Product Characteristics
Hameln Pharmaceuticals 2010

  Mentions Légales